Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Funafuti Tech Report.
Press releases published on September 3, 2025

Mavenir เริ่มใช้งานระบบการชาร์จหลายผู้เช่าแบบรวมศูนย์สำหรับผู้ให้บริการในแคริบเบียน SETAR
ริชาร์ดสัน รัฐเท็กซัส, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mavenir ผู้ให้บริการโครงสร้างพื้นฐานเครือข่ายแบบคลาวด์เนทีฟ ประกาศความสำเร็จในการดำเนินการเสร็จสิ้นและเปิดใช้งานระบบการชาร์จแบบรวมศูนย์ (CCS) สำหรับ SETAR …

Mavenir 正式上线面向加勒比运营商 SETAR 的多租户融合计费系统
理查森,德克萨斯州, Sept. 03, 2025 (GLOBE NEWSWIRE) -- 云原生网络基础设施提供商 Mavenir 今日宣布,已成功完成并正式上线了融合计费系统 (CCS) 改造项目,为加勒比海岛国阿鲁巴的全方位电信服务主要提供商 SETAR 提供支持。这款云原生多租户融合计费系统目前正为阿鲁巴的 SETAR N.V. 运营提供支持,并使 SETAR 能够向邻近的博内尔岛移动运营商 KLA 提供“计费即服务” (Charging as a Service) 解决方案。 这套集中式系统依托 …

Mavenir 為加勒比海營運商 SETAR 上線多租戶融合計費系統
理查森,德州, Sept. 03, 2025 (GLOBE NEWSWIRE) -- 雲端原生網絡基礎設施供應商 Mavenir 今日宣佈,其為加勒比海島國阿魯巴主要全方位電訊服務供應商 SETAR 進行的融合計費系統 (CCS) 轉型已成功完成並上線運作。此雲端原生多租戶 CCS 正支援 SETAR N.V. 在阿魯巴的營運,讓 SETAR 能為鄰近島嶼波奈的流動服務營運商 KLA 提供「計費即服務」解決方案。 在 Mavenir 數碼賦能 (MDE) 解決方案的推動下,該集中式系統以統一的多租戶系統取代 …

Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
ISELIN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will present at …

Banzai to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025
SEATTLE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that Joe Davy, Founder and CEO …

Journey Medical Corporation to Participate in September 2025 Investor Conferences
SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (“ …

Live Ventures Announces New Communications Campaign, Engages Brandsinger Agency to Facilitate
LAS VEGAS, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company that focuses on value-oriented acquisitions of domestic middle-market companies, today announced a strategic campaign to tell its story …

VelocityEHS Publishes Breakthrough AI Research to Reduce Hand Strain and Injury on the Job
CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- VelocityEHS, global leader in EHS solutions and pioneer of practical AI for workplace safety, today announced the publication of “Vision-Based Computing Pipeline for Recognizing Hand Grip-Types During Tool …

PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
PETACH TIKVA, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that senior management will participate in the upcoming …

Thrive Launches Managed AI Services to Help Businesses Succeed with AI
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Thrive, a global technology outsourcing provider for cybersecurity, cloud, and IT managed services, today announced its Managed AI services, a new offering that provides mid-market businesses with a dedicated team …

Aterian Announces U.S. Launch of Squatty Potty Flushable Wipes
Newest Bathroom Essential from the Creators of the #1 Way to #2 100% Plant-Based Fibers, Hypoallergenic, and Septic Safe SUMMIT, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the launch …

Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
Live moderated webcast on Thursday, September 4th at 4:00 PM ET Access the event here BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload …

Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral Neuropathic Pain Patient Insights at PAINWeek 2025
THE WOODLANDS, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced data from a study of patients describing the physical and psychological impact of diabetic peripheral neuropathic pain (DPNP), despite …

CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today announced that, following its strategic review of the cryptocurrency and stablecoin market, engagement with third- …

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA acceptance starts the review process and sets timing for potentially the first new FDA-approved …

Coherus Oncology to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today announced that the company will be webcasting its participation in the following upcoming conferences: Baird 2025 Global Healthcare Conference in New York, …

IQSTEL and Cycurion Execute $1 Million Stock Exchange, Announce Dividend Distribution and Strategic AI Cybersecurity Alliance
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- IQSTEL Inc. (NASDAQ: IQST) (“IQSTEL”) and Cycurion Inc. (NASDAQ: CYCU) (“Cycurion”) today announced the execution of their previously announced $1 million stock exchange, finalizing the mutual equity agreement …

SaverOne Signs Agreement with Fandango to Deploy its Driver Distraction Prevention Solution Across Heavy Truck Fleet
Expands Presence in Heavy-Truck Sector, Reinforcing Strategic Penetration into High-Risk Commercial Fleets Petah Tikvah, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in …

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that IP Australia (the Australian Patent …

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
10-minute home test detects early kidney damage in diabetic and hypertensive patients Hypertension affects roughly one-third of adults in the UAE Diabetes impacts approximately one in four UAE nationals IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- …